Archive for the ‘BVI Holding Companies’ Category

BVI holding extends collaboration with Canada-based NetraMark Corp

Saturday, December 14th, 2019

Life sciences company Juvenescence Limited and next generation AI + health data technology company NetraMark Corp. announced the extension of their collaboration agreement to include drug repurposing and discovery.

NetraMark is a Canada-based tech venture with dedicated solutions for pharmaceutical and biotech companies. Company’s AI platform was designed to extract insights from complex patient populations for patient stratification, placebo response prediction, drug repurposing, and precision multi-target identification.

CEO of the BVI holding Dr. Greg Bailey commented: “NetraMark Corp. and Juvenescence Limited are pleased to announce the extension of their business relationship. We are very excited to extend the relationship with NetraMark beyond drug resurrection to also include drug repurposing and drug discovery to find novel drugs and drug targets relating to longevity. We see this as a novel collaboration to combine NetraMark’s diverse and unique machine learning platform with Juvenescence, as we are positioned as one of the leading drug development companies in the rapidly expanding sector focused on developing therapies to modify aging.”

AgeX Therapeutics and its BVI-registered investor Juvenescence Ltd. announced publication of paper on the engineering of universal cells

Saturday, November 2nd, 2019

Juvenescence Ltd., BVI-registered science company developing technologies to treat aging, and AgeX Therapeutics, Inc., a biotechnology company developing therapeutics for human aging and regeneration, announced the publication of a new paper in the scientific journal Regenerative Medicine. The published paper is on the strategies of engineering of allogeneic cells to be hypoimmunogenic (universal), so as not to produce an immune response. Also, the paper presents previously unpublished observation in vivo on allogeneic human stem cells (hPSCs).

The leading author of the paper is Dr. Nafees Malik, Chief Operating Officer at AgeX and Head of Cell & Gene Therapy at Juvenescence, which is a major investor in AgeX. His co-authors on the paper are Gregory Bailey, MD, Chairman of the Board of Directors of AgeX and CEO of Juvenescence; Annalisa Jenkins, MBBS, FRCP, who serves on the Board of Directors of AgeX; and Jim Mellon, Chairman of Juvenescence.

Dr Malik said in his comments on the publication: “This is a huge area of focus for us at AgeX, via our UniverCyte technology platform. In support of our own research and as a service to the overall field, we decided to put together this paper, analyzing all the leading strategies to engineer universal cells and encapsulating them in one paper.”

Aura Minerals appointed new director and new general manager for Honduras operations

Saturday, October 19th, 2019

Aura Minerals Inc., BVI-incorporated mining company engaged in the production and development of gold mines in the North, South and Central America, announced the appointment of Richmond Fenn to the company’s Board of Directors. The appointment is effective from October 7, 2019.

Mr. Fenn already worked with the company as interim-General Manager for the San Andrés operations. He has extensive experience in mine engineering, mine development and valuation, maintenance and operations in North and South America, Africa and Papua New Guinea. Prior to joining Aura, he was Executive General Manager for the Pueblo Viejo mine in the Dominican Republic, one of the world’s largest gold producing mines. Mr. Fenn holds a bachelor´s degree in mining engineering and is a registered professional engineer.

The BVI company also announced the appointment of Julio Cesar Beraun as the new General Manager of operations in Honduras effective September 26, 2019. Mr. Beraún is an industry professional who successfully led the engineering and implementation of innovation projects for optimization of mining procedures.

Origin entered into collaboration agreement with INOVA, Brazil

Thursday, September 19th, 2019

BVI-registered Origin Agritech Ltd. entered into a collaboration agreement with Inova Genética Ltda (INOVA), a member of the Wehrmann Group, which is an active participant of the seed industry and a leading vegetable production company in Brazil. The agreement between the agriculture technology company and INOVA provides for co-operation in field testing of hybrids of both companies in each other’s geographic regions.

INOVA will also co-operate with the BVI company to evaluate corn seed biotechnology traits for application in South American markets. Origin and INOVA will explore commercial opportunities between the companies in corn seed breeding, production and distribution in South America. INOVA is focused on the plant breeding business and is headquartered in Cristalina-GO, Brazil.